Axovant Sciences
Data Breaches, Cyber Attacks and Security Report

https://axovant.com  ᛫ 
Last updated November 12, 2019

About Axovant Sciences

Company Overview

Axovant Sciences Ltd. is a clinical-stage pharmaceutical company that develops small molecule drugs to treat neurological disorders.

Valuation

Employees

CEO

David T. Hung

Location

Data Breaches and Security News

Axovant Sciences Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Axovant Sciences is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Axovant Sciences

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Axovant Sciences's security performance with other companies